Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow‐up at 3 years

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Alzheimer's & Dementia

• Publication date

  2010-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jalz.2009.09.005PMID 20447873PMCID PMC2918397
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LIBSVM: A library for support vector machines

  2011cited by this paper
• Microglial activation and amyloid deposition in mild cognitive impairment

  2009cited by this paper
• Faculty Opinions recommendation of Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.

  2009cited by this paper
• Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease

  2008cited by this paper
• Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study

  2008influential reference
• Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

  2008cited by this paper
• Atrophy rates accelerate in amnestic mild cognitive impairment

  2008cited by this paper
• 18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease

  2007cited by this paper
• Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans

  2007cited by this paper
• Where the brain grows old: Decline in anterior cingulate and medial prefrontal function with normal aging

  2007influential reference
• Neuropathologic substrate of mild cognitive impairment.

  2006cited by this paper
• Mortality in amnestic mild cognitive impairment

  2006cited by this paper
• Feature Extraction, Foundations and Applications

  2006cited by this paper
• Feature Extraction: Foundations and Applications (Studies in Fuzziness and Soft Computing)

  2006cited by this paper
• Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

  2005influential reference
• CO-OCCURRENCE MATRICES FOR VOLUMETRIC DATA

  2004cited by this paper
• Mild cognitive impairment, amnestic type

  2004cited by this paper
• Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease)

  2003cited by this paper
• Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

  2003cited by this paper
• Mapping cortical change across the human life span

  2003cited by this paper
• Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank

  2002cited by this paper
• Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET

  2002cited by this paper
• Mild cognitive impairment represents early-stage Alzheimer disease.

  2001influential reference
• Current concepts in mild cognitive impairment.

  2001cited by this paper
• Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET)

  2001cited by this paper
• Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

  2001cited by this paper
• Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

  2001cited by this paper
• Hippocampal formation glucose metabolism and volume losses in MCI and AD.

  2001cited by this paper
• Classification criteria for mild cognitive impairment

  2001cited by this paper
• Automated Talairach Atlas labels for functional brain mapping

  2000cited by this paper
• Development and standardization of a new telephonic cognitive screening test: the Minnesota Cognitive Acuity Screen (MCAS).

  2000cited by this paper
• Advances in kernel methods: support vector learning

  1999cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999influential reference
• Making large scale SVM learning practical

  1998cited by this paper
• Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

  1997cited by this paper
• A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

  1995cited by this paper
• Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

  1994cited by this paper
• Posterior cingulate cortex in Alzheimer's disease.

  1994cited by this paper
• An automated method for rotational correction and centering of three-dimensional functional brain images.

  1992cited by this paper
• BMC Medical

  year unknowncited by this paper

• Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum.

  2025cites this paper
• Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review

  2023cites this paper
• Brain 18F‐FDG‐PET and an optimized cingulate island ratio to differentiate Lewy body dementia and Alzheimer's disease

  2022cites this paper
• MRI-based machine learning model: A potential modality for predicting cognitive dysfunction in patients with type 2 diabetes mellitus

  2022cites this paper
• F-18 ML-104 tau PET imaging in mild cognitive impairment

  2021cites this paper
• Artificial intelligence for diagnosis and prognosis in neuroimaging for dementia; a systematic review

  2021cites this paper
• A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination

  2019cites this paper
• Imaging in prodromal dementia with Lewy bodies: Where do we stand?

  2019cites this paper
• Clinical utility of FDG-PET for the clinical diagnosis in MCI

  2018cites this paper
• 18F-FDG PET for Prediction of Conversion to Alzheimer’s Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy

  2018cites this paper
• Psychiatry Research: Neuroimaging

  2016cites this paper
• Biomarkers in dementia with Lewy bodies

  2016cites this paper
• Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.

  2016cites this paper
• A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives

  2015cites this paper
• ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

  2014cites this paper
• Prodromal dementia with Lewy bodies

  2014cites this paper
• The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis

  2014cites this paper